Wednesday, May 14 2008
Digitek Lawsuits filed for Digitek, Bertek & UDL Digoxin Injuries & Deaths Due to large numbers of Digitek users that have experienced digitalis toxicity and others that have lost loved ones due to Digitek overdose / Digitalis Toxicity, the Willis Law Firm is representing dozens of Digitek victims and their families in Digitek lawsuit litigation. We intend to file a Digitek lawsuit against the manufacturers and distributors of Digetek, Bertek & UDL Digoxin products that are included in the FDA recall namely Mylan, Actavis, & UDL. FDA Recall of Digitek Morristown, NJ -- April 25, 2008 -- Actavis Totowa LLC, a United States manufacturing division of the international generic pharmaceutical company Actavis Group, is initiating a Class I nationwide recall of DigitekŪ (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. (See:FDA Recall of Digitek.) What is Digitek or Digitalis? DigitekŪ is used to treat heart failure and abnormal heart rhythms. The existence of double strength tablets poses a risk of digitalis toxicity in patients with renal failure. Digitalis toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia. Death can also result from excessive Digitalis intake. FDA has received many reports of serious illnesses and injuries regarding digitalis toxicity. (See:Digitek Overdose Side Effects) The voluntary all lot recall is due to the possibility that tablets with double the appropriate thickness may have been commercially released. These Digitek tablets may contain two times the approved level of active ingredient than it appropriate. Digoxin Overdose Death Lawsuit - Contact a Lawyer If you or a loved one have been seriously injured or a loved one has died as a result of this digitalis toxicity or an overdose of Digitek, Bertek and/or UDL Digoxin, please contact us immediately for a Free Digitek Lawsuit Evaluation Nationwide Help is Available Monday, May 12 2008
What is Digoxin or Digitalis?
Digoxin also known as Digitalis, is a purified cardiac glycoside extracted from the foxglove plant. It works by affecting certain minerals (sodium and potassium) inside the cells of the heart. This reduces strain on the heart and helps it beat more strongly Digoxin is widely used in the treatment of various heart conditions, namely atrial fibrillation, atrial flutter and sometimes heart failure that cannot be controlled by other medication. Digoxin preparations are commonly marketed under the trade names Lanoxin, Digitech, and Lanoxicaps.
Digitek Recall
Actavis Totowa LLC, a division of Actavis Group, is initiating a Class I nationwide recall of DigitekŪ (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. Actavis manufactures the products for Mylan and the products are distributed by Mylan and UDL under the Bertek and UDL labels. Bertek and UDL are affiliates of Mylan. Digitek lawsuits are being filed
The voluntary recall of Digitek includes all lots, due to the possibility that Digetek tablets were made with double the appropriate thickness may have been commercially released. These tablets may contain twice the approved level of active ingredient than it appropriate which can result in digitalis toxicity, nausea, vomiting, dizziness, low blood pressure, cardiac instability, bradycardia and death. DigitekŪ is used to treat heart failure and abnormal heart rhythms. The existence of double strength tablets poses a risk of digitalis toxicity in patients with renal failure
Digitek Lawsuits - Contact a Lawyer
If you or a loved one have been seriously injured or a loved one has died as a result of this digitalis toxicity or an overdose of Digitek, please call us immediately for a Free Digitek Recall Lawsuit Evaluation to learn more information on whether your case should be filed as a separate lawsuit or part of a global Digitek Class Action Lawsuit. Get the facts about which is best for you.
Nationwide Help is Available
Sunday, May 11 2008
Mylan's Bertek Digoxin & UDL Digoxin Recall Announced by FDA FDA has announced a Class 1 recall of all Digitek (digoxin) tablets. These Digitek tablets may contain two (2) times as much of digoxin causing potential digitalis toxicity, which can result in nausea, rapid heart beat, vomiting, lo blood pressure, cardiac instability, bradycardia and even death. Digitek is a registered trademark of Actavis Totowa (formerly Amide Pharmaceutical, Inc.) for their digoxin tablets, which are prescribed to treat heart failure and abnormal heart rhythms. The drug is distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. DigitekŪ is used to treat heart failure and abnormal heart rhythms. The existence of double strength tablets poses a risk of digitalis toxicity in patients with renal failure. Digitalis toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia. Death can also result from excessive Digitalis intake. Several reports of illnesses and injuries have been received. ( See: Digitek Overdose Side Effects) UDL Digoxin Recall & Bertek Recall Lawsuits - Contact a Lawyer If you or a loved one have been seriously injured or a loved one has died as a result of this digitalis toxicity or an overdose of Digitek Digoxin, UDL Digoxin or Bertek Digoxin, please call us immediately for a Free Digitek Toxicity Lawsuit Evaluation Nationwide Help is Available Thursday, May 08 2008
Digitek Recall Announced by FDA Digitek (digoxin tablets, USP) Cardiologists, family physicians, pharmacists, other healthcare professionals, patients [Posted 04/28/2008] Actavis Totowa LLC notified healthcare professionals of a Class I nationwide recall of all strengths of Digitek, a drug used to treat heart failure and abnormal heart rhythms. The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. The product is being recalled due to the possibility that tablets with double the appropriate thickness may contain twice the approved level of active ingredient. The existence of double strength tablets poses a risk of digitalis toxicity in patents with renal failure. Digitalis toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia. Several reports of illnesses and injuries have been reported. Patients should contact their healthcare professional with questions. Digitek Injury Lawsuits - Contact a Lawyer If you or a loved one have been seriously injured or a loved one has died as a result of this digitalis toxicity or an overdose of Digitek, please call us immediately for a Free Case Evaluation. Nationwide Help is Available
Tuesday, May 06 2008
Digitek Recall Announced Morristown, NJ -- April 25, 2008 -- Actavis Totowa LLC, a United States manufacturing division of the international generic pharmaceutical company Actavis Group, is initiating a Class I nationwide recall of DigitekŪ (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. ( See:FDA Recall of Digitek) |